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SUMMARY
Cognitive deficits are central to schizophrenia but the underlying mechanisms still remain unclear.
Imaging studies performed in patients point to decreased activity in the medio-dorsal thalamus
(MD) and reduced functional connectivity between the MD and prefrontal cortex (PFC) as
candidate mechanisms. However, a causal link is still missing. We used a pharmacogenetic
approach in mice to diminish MD neuron activity and examined the behavioral and physiological
consequences. We found that a subtle decrease in MD activity is sufficient to trigger selective
impairments in prefrontal-dependent cognitive tasks. In vivo recordings in behaving animals
revealed that MD-PFC beta-range synchrony is enhanced during acquisition and performance of a
working memory task. Decreasing MD activity interfered with this task-dependent modulation of
MD-PFC synchrony, which correlated with impaired working memory. These findings suggest
that altered MD activity is sufficient to disrupt prefrontal-dependent cognitive behaviors, and
could contribute to the cognitive symptoms observed in schizophrenia.
INTRODUCTION
Schizophrenia is a devastating mental disorder characterized by three clusters of symptoms:
positive symptoms (psychosis and thought disorder), negative symptoms (social and
emotional deficits) and cognitive symptoms. Understanding the cognitive symptoms of
schizophrenia is of particular significance because they are highly predictive for the long-
term prognosis of the disease and at present they are essentially resistant to treatment
(Green, 1996). Cognitive symptoms include deficits in working memory and behavioral
flexibility (Forbes et al., 2009; Leeson et al., 2009), two processes of executive function that
are essential for activities of daily living. Functional magnetic resonance imaging studies
have consistently shown an association between impaired executive function and altered
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activity in the prefrontal cortex (PFC) of patients, leading to the influential hypothesis that
prefrontal dysfunction underlies the cognitive symptoms of schizophrenia (Weinberger and
Berman, 1996). Due to its dense excitatory reciprocal connection with the PFC (Jones,
2007), the medio-dorsal thalamus (MD) has become a focus of attention in the study of
cognitive symptoms. Imaging studies have repeatedly shown decreased activation of the MD
in patients under a variety of test conditions that address executive functions (Andrews et
al., 2006; Minzenberg et al., 2009). Altered correlation between activity in the MD and the
PFC at rest or during cognitive testing has also been observed (Minzenberg et al., 2009;
Mitelman et al., 2005; Woodward et al., 2012). These findings suggest that altered MD
activity and/or impaired communication between the MD and PFC could play a role in the
cognitive deficits seen in schizophrenia patients.
A major limitation of brain imaging studies is that they cannot draw causal relationships
between measured physiological alterations and specific symptoms. As such, it remains
unclear whether decreased MD activity is a cause or a consequence of schizophrenia and its
associated cognitive dysfunction. Lesion studies in animal models have made a first step
toward a better understanding of the roles of the PFC and the MD in executive function.
While such studies clearly involved the PFC in executive function in humans (Bechara et al.,
1998; Hornak et al., 2004), non-human primates (Funahashi et al., 1993; Rygula et al., 2010)
and rodents (Kellendonk et al., 2006; Schoenbaum et al., 2002), the function of the MD in
cognition is more controversial. Whereas a number of groups have reported an impairment
in working memory and reversal learning tasks in MD lesioned rats (Bailey and Mair, 2005;
Block et al., 2007; Chudasama et al., 2001; Floresco et al., 1999; Hunt and Aggleton, 1998),
several other studies did not observe such effects (Beracochea et al., 1989; Hunt and
Aggleton, 1991; Mitchell and Dalrymple-Alford, 2005; Neave et al., 1993).
The interpretation of lesion studies is difficult in the context of imaging studies. Indeed,
imaging studies have merely reported a decrease in the activity of the MD, while lesion
studies physically and irreversibly ablate the entire structure. Imaging studies further suggest
that the MD cooperates with the PFC during cognitive processes, but the nature of this
relationship cannot be addressed by lesion studies in which both structures do not remain
intact. To address these questions and to circumvent these limitations, we therefore used a
recently developed pharmacogenetic approach, the DREADD (Designer Receptor
Exclusively Activated by a Designer Drug) system (Armbruster et al., 2007; Garner et al.,
2012; Ray et al., 2011) to selectively and reversibly decrease neuronal activity in the MD of
mice performing cognitive tasks. We found that a relatively mild decrease in the activity of
MD neurons is sufficient to trigger selective impairments in two prefrontal dependent
cognitive tasks: an operant-based reversal learning task and a delayed non-matching to
sample (DNMS) working memory task. To investigate the nature and the role of MD-PFC
communication in working memory we recorded simultaneously from both structures in
mice performing the DNMS task. We found that synchronous activity between MD and
medial PFC (mPFC) increased hand in hand with choice accuracy during the learning of the
task and that reducing MD activity delayed both learning and the strengthening of
synchrony. Interestingly, in trained animals, the strength of MD neurons phase-locking to
medial prefrontal oscillations in the beta frequency range (13-30 Hz) increased specifically
during the choice phase of the task associated with peak mnemonic demand, suggesting a
role for MD-PFC beta synchrony in working memory. Strikingly, a primary decrease in the
firing of MD neurons selectively disrupted this task-specific increase in MD-PFC beta-
synchrony. In conclusion, our results demonstrate a causal relationship between decreased
MD activity and deficits in executive function. They further suggest thalamo-frontal beta
synchrony as a potential mechanism contributing to working memory.
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Decrease of medio-dorsal thalamus neurons activity using DREADD system
A modified human muscarinic receptor, hM4D, was co-expressed along with humanized
renilla green fluorescent protein (hrGFP) selectively in the MD using an adeno-associated
virus expression system (AAV2-hM4D-IRES-hrGFP) (Figure 1A). The hM4D receptor is
activated solely by a pharmacologically inert compound, clozapine-N-oxide (CNO), and not
by endogenous acetylcholine or any other neurotransmitter. Upon CNO activation, hM4D
hyperpolarizes neurons through a G-protein mediated activation of inward-rectifying
potassium channels (Armbruster et al., 2007). Stereotactic injection of AAV2-hM4D-IRES-
hrGFP virus into the MD induced co-expression of both GFP (green) and hM4D as assessed
by anti-HA immunostaining (red) (Figure 1B). At higher magnification, we observed that
the hM4D is localized in the plasma membrane as well as in neuronal processes (Figure 1B,
D). Co-staining with anti-NeuN antibodies revealed that GFP expression was exclusively
neuronal (Figure 1C top panel). Due to the absence of interneurons in rodents MD (Kuroda
et al., 1998), all infected neurons should be relay projection neurons. Using AAV2.2, an
average of 27 ±6% of the MD neurons expressed the GFP with a peak at 66 ±9.6% at the
site of injection (Figure 1C bottom panel). The virus spread almost entirely among the
anterio-posterior axis of the MD whereas it stayed constrained within the dorso-ventral and
latero-medial axis of the MD (Figure 1C and S1A). Consistent with the known anatomy of
the MD (Kuroda et al., 1998), infected neurons projected to layers I and III/V of prelimbic
and orbito-frontal cortices (Figure 1D).
To determine whether activation of hM4D will hyperpolarize thalamic neurons as has been
shown for hippocampal neurons (Armbruster et al., 2007), we performed whole-cell patch
clamp recordings from thalamic slices. Fluorescently-identified neurons expressing hM4D
were significantly hyperpolarized after CNO bath application, while the resting membrane
potential of cells infected with a control virus expressing only hrGFP were not (Figure 2A).
To determine whether activation of hM4D reduces the activity of MD neurons in vivo, we
performed multiple single-unit recordings from the MD of freely moving mice injected with
AAV2-hM4D-IRES-hrGFP (MDhM4D mice). For this experiment, mice were exploring a
familiar environment, specifically a T-maze to which they had been previously habituated.
63 single-units were recorded both after systemic injection of saline and 2 mg/kg CNO. The
dose of CNO was chosen based on a previous study reporting high in vivo efficacy at doses
between 1 and 5 mg/kg on locomotor activity and stereotypy in a transgenic mouse
expressing the hM3Dq receptor within the forebrain (Alexander et al., 2009). CNO reduced
the firing rate of a substantial portion of the MD units (Figure 2B-D). To quantify this effect,
we first calculated the ratio of firing rates after saline and CNO for each unit; the
distribution of ratios in the sample was significantly different than that expected by chance
(p<0.01, Wilcoxon signed-rank test) (Figure 2C). We next compared firing rates after saline
and CNO injections for each neuron independently. CNO decreased firing rate significantly
(p<0.05 by paired t-test) in 30 neurons (48%). In an additional 11 units (17%), CNO
increased the firing rate. Using a more stringent Bonferroni correction (p<0.0008) 16 (25%)
and 6 (9.5%) units were inhibited or activated by CNO, respectively. For both analyses
neurons with decreased firing rate were overrepresented as a consequence of CNO treatment
(Binomial test: p<0.01, p<0.05 for Bonferonni-corrected values). Importantly, CNO
treatment did not completely silence MD neurons; the neurons with decreased firing rate
showed an average decrease of 38.7+-5.3%. This decrease in firing rate was not related to
changes in locomotor activity or to differences in the isolation of single units (Figure S2A-
C). The CNO-mediated decrease in firing rate was not observed in wild type mice that do
not express hM4D, demonstrating its dependence on hM4D (Figure 2C inset). While
hyperpolarization of thalamic cells can induce a shift in the firing pattern from a tonic to a
bursting mode due to the activation of T-type Ca2+ channels (Jahnsen and Llinas, 1984), we
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did not observe a significant change in the fraction of burst firing in vivo after CNO
injection (Figure S2D).
Decreasing MD activity leads to deficits in tasks addressing behavioral flexibility and
working memory
Due to the strong projections of the MD to the orbital-frontal cortex (Figure 1E) we first
tested whether decreasing MD activity affects reversal learning, a cognitive process of
executive function that is sensitive to orbito-frontal (OFC) lesions (Schoenbaum et al.,
2002). To address reversal learning, we developed an operant-based reversal learning task
for the mouse in which lever presses are rewarded in the presence of one visual cue (S+), but
not in the presence of another visual cue (S-) (discrimination phase). After mice reached
criterion the contingencies were reversed (reversal phase) (Figure 3A). The acquisition of
the discrimination phase was not affected by decreasing MD activity (repeated ANOVA
p=0.17) though CNO-treated MDhM4D mice showed a tendency for a delay in learning
during the first three days of acquisition (Figure 3B). In contrast, reversal learning was
clearly impaired in CNO-treated MDhM4D mice when compared to the three control groups
(repeated ANOVA followed by bonferroni correction for group comparisons *p<0.05,
**p<0.01) (Figure 3C). As has been observed for OFC lesions, these deficits were likely due
to perseverative behavior, as mice with reduced MD activity made significantly more S-
responses (previously rewarded during the discrimination phase) than the control groups
over the seven sessions of the reversal phase (repeated ANOVA followed by bonferroni
correction for group comparisons *p<0.05, ***p<0.001) (Figure 3D). This perseverative
behavior was evident even within the first trials of the first reversal session, in which control
mice were able to repress their number of S- responses while CNO-treated MDhM4D mice
were not (Figure S3A and B).
To address working memory, we performed a delayed non-matched to sample (DNMS) T-
maze task commonly used in rodents (Figure 4A). Deficits in both acquisition and
performance of this task have been observed after lesioning or silencing the mPFC in rats
and mice (Dias and Aggleton, 2000; Kellendonk et al., 2006; Yoon et al., 2008). Similarly,
decreasing MD activity with CNO led to a deficit in the acquisition of the task, as CNO-
treated MDhM4D mice showed took longer to reach learning criterion than controls
(ANOVA followed by Newman-Keuls correction for group comparisons *p<0.05) (Figure
4B). To determine whether decreasing MD activity also affects working memory
performance, a second cohort of hM4D- and GFP-expressing mice was trained without CNO
until they reached criterion (Figure S4A). Working memory performance was then tested
after CNO or saline treatment at delays ranging from 6 to 120 s. In this cohort the number of
animals was too low for a statistical comparison of all four groups. Since the three control
groups did not differ in their performance (Figure S4B), they were combined for their
comparison with CNO-treated MDhM4D mice. CNO-treated MDhM4D mice performed as
well as the controls on the shorter delays (6 and 30 s) but showed significantly poorer
performance on longer delays (repeated ANOVA group effect **p<0.01) (Figure 4C). The
observed deficits were not due to a general attention deficit or deficits in learning the spatial
contingencies of the task, as mice with decreased MD activity showed performance
comparable to that of control mice in a T-maze based spatial reference memory task (Figure
4D). Moreover, we did not observe any general alterations of locomotor activity or anxiety-
like behavior as assessed in open field and elevated plus maze tests that may interfere with
performance in the reversal learning or in the DNMS T-maze task (Figure S4C and D).
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Working memory-induced modulation of thalamo-prefrontal beta synchrony is disrupted
by low MD activity
Based on imaging studies reporting deficits in functional connectivity between different
areas of the brain in patients, the disconnection theory (Pettersson-Yeo et al., 2011) posits
schizophrenia as a subtle but pernicious syndrome of decreased long-range connectivity. In
agreement with this theory, alterations in functional connectivity between MD and PFC have
been observed in patients engaged in executive function tasks, including working memory
(Minzenberg et al., 2009; Mitelman et al., 2005). To determine whether spatial working
memory in mice involved MD-PFC synchrony, we recorded neural activity simultaneously
in the MD and mPFC of mice performing the T-Maze DNMS task. If MD-PFC synchrony is
involved in working memory, it should specifically be modulated during the choice phase of
the DNMS T-Maze task, when the mnemonic requirement is high. For example, recent
studies have shown that theta-frequency synchrony between the dorsal hippocampus (dHPC)
and mPFC is modulated by the DNMS task (Jones and Wilson, 2005; Sigurdsson et al.,
2010). These studies found that phase-locking of PFC units to the theta-frequency
component of the hippocampal local field potential (LFP) was enhanced during the choice
phase of the DNMS task (which requires working memory) compared to the sample phase
(which does not).
We therefore examined MD unit phase-locking to mPFC LFPs across multiple frequency
ranges in trained animals performing the DNMS T-maze task. In saline treated mice, the
phase-locking of MD units to beta-frequency (13-30 Hz), but not theta (4-12 Hz) or gamma-
frequency (40-60 Hz) PFC oscillations, was strengthened in the choice phase (two tailed
paired t-test, **p<0.01) (Figure 5A) suggesting that MD-PFC synchrony in the beta range is
selectively modulated by working memory. Looking at individual units, about half of units
(17/40; 42.5%) noticeably increased their phase locking to mPFC beta-oscillations during
choice phase while phase-locking did not change or decreased in 18/40 (47.5%) and 4/40
(10%) units, respectively (Figure S5A). Strikingly, the increase in MD-PFC beta synchrony
was selectively disrupted in CNO-treated MDhM4D mice (repeated ANOVA, task phase x
treatment interaction #p<0.05) (Figure 5A). This was observed as well in mice that never
received CNO injection prior the recording ruling out that these effects could be due to
chronic effects of the drug (Figure S5E). Phase-locking to other frequency ranges was
unaffected. Examining individual cells, we observed a significant reduction (Odd ratio=0.09,
p<0.001) of the percentage of neurons increasing their phase locking (2/33; 6.1%) and a
significant increase (Odd ratio=5.5, p<0.01) of the percentage of cells showing no changes
(27/33; 81.8%) in CNO-treated mice compared to controls (Figure S5A). The effects of
decreasing MD activity on the sample/choice difference in phase-locking was also
confirmed using the pairwise phase consistency measure that controls for spike history
effects such as bursting (Figure S5F) (Vinck et al., 2012).
To rule out the possibility that CNO-treatment affected the quality of unit isolation, we
confirmed that this disruption in MD-PFC beta synchronization was not due to differences in
unit quality (Figure S5B and C). To examine the specificity of disrupted communication
between the MD and mPFC we also measured synchrony between the MD and the dHPC, a
structure that is also important for spatial working memory. While no task-related
modulation of phase-locking strength was observed in the beta and gamma range, a decrease
of phase locking between MD single-unit activity and dHPC theta-oscillations occurred
during the choice phase of the DNMS task (Figure 5B, two tailed paired t-test, ***p<0.001).
However, this decrease was not altered by CNO treatment (Figure 5B). Power spectra in the
MD and mPFC were unchanged by CNO, suggesting that the effects of reducing MD
activity were specific to the connectivity between the two regions rather than alterations in
the strength of oscillations in either region (Figure S5D). We also examined the effects of
CNO task-related firing in the recorded MD units, examining whether firing rates in the start
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arm of the T-maze were modulated across sample vs. choice, right vs. left, or error vs.
correct trials. In saline treated mice, 40% (21/51) of our recorded units were firing in a task-
related manner. We saw a non-significant trend towards a reduction in the percentage of
task-related MD cells in CNO-treated mice as 31% (17/54) exhibited task-related activity.
Together, these results suggest that decreasing MD activity may impair working memory by
disrupting MD-PFC beta synchrony during the choice phase of the task. In line with this
interpretation, we found an increase of the proportion of MD cells significantly phase locked
to mPFC beta oscillations when trained control mice were performing the task (61/69 cells,
88%) compared to mice that were simply exploring the maze (15/59 cells, 25%) (Odds
ratio=22.37, p<0.001). Lag analysis revealed a predominant MD to mPFC directionality in
the beta-frequency range. Phase locking of each MD unit was calculated repeatedly after
systematically shifting the MD action potentials forward and backward in time relative to
the mPFC LFP (Siapas et al., 2005). MD units tended to phase lock strongest to the mPFC
beta-frequency oscillation of the future (mean lag, +20 ± 1.4 ms, wilcoxon signed rank test
p<0.05, n=76) (Figure 5C). This finding is consistent with the possibility that information
tends to flow from the MD to the mPFC during the DNMS task.
Beta-frequency synchrony parallels behavior during working memory task acquisition
The parallel effects of MD inhibition on phase-locking and behavior after successful task
acquisition suggest a role for the MD and MD-PFC connectivity in working memory
performance. Yet CNO-treated MDhM4D mice also had a deficit in task acquisition (Figure
4B). To determine whether altered MD-PFC functional connectivity could account for the
deficits observed in task acquisition observed in CNO-treated MDhM4D mice, we examined
MD-PFC synchrony in an additional cohort of MDhM4D mice treated with daily injections of
CNO or saline during acquisition of the DNMS T-maze task. Because the training period is
too brief to permit recording of a sufficient sample of MD units, coherence between MD and
PFC LFPs was used to measure synchrony. As with the first cohort, CNO-injected MDhM4D
mice took significantly longer to acquire the task than saline-injected MDhM4D mice (Figure
S6A and B). Consistent with a role for MD-PFC connectivity in task learning, LFP
coherence between these two structures increased with task acquisition in both CNO- and
saline injected MDhM4D mice (Figure 6A and S6C). Strikingly, coherence in beta-frequency
range increased hand in hand with performance (Figure 6B). In control mice, increases in
coherence and choice accuracy occurred simultaneously at the end of 2nd session (trials
15-20). In contrast, both coherence and choice accuracy started to increase later in CNO-
treated MDhM4D mice (session 5, trials 41-45) (repeated ANOVA followed by Fischer
correction, difference vs trials 1-5: °p<0.1, *p<0.05, **p<0.01, ***p<0.001). In addition, we
did an analysis of correlation between coherence and performance for each session and each
individual animal and found that coherence correlated significantly with behavioral
performance for both saline- and CNO-treated MDhM4D mice. Finally, the parallel increase
of coherence and performance was also seen in the theta-frequency range (Figure S6D-E). In
contrast, while gamma-frequency coherence also increased between early and late training
phases in both saline and CNO-treated MDhM4D mice, these increases did not correlate with
increases in choice accuracy (Figure S6B-E). These data, together with the phase-locking
findings, demonstrate that inhibition of MD disrupts both MD-PFC functional connectivity
and working memory behavior in parallel, during task acquisition as well as task
performance.
DISCUSSION
Imaging studies have repeatedly reported deficits in MD and PFC activation in
schizophrenia patients performing cognitive tasks. However, whether a decrease in MD
activity can cause cognitive deficits is unclear. Moreover, the potential role for MD-PFC
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dysconnectivity in the generation of cognitive symptoms still remains unexplored. Here, by
inducing a subtle decrease in the firing of MD neurons, we triggered selective deficits in two
prefrontal-dependent tasks that address reversal learning and working memory, cognitive
processes impaired in patients with schizophrenia. We further found that beta range
synchrony between the MD and the mPFC is modulated by working memory, and that this
modulation is disrupted by the decrease in MD activity. Finally, during DNMS task
acquisition, the magnitude of MD-PFC coherence increased in tight correlation with choice
accuracy and both increases were delayed by inhibition of MD activity. Together these data
demonstrate that decreased MD activity disrupts functional communication within the MD-
PFC circuit and causes deficits in prefrontal-dependent cognition. Our findings are
consistent with a role for MD-PFC synchrony in working memory tasks, and further support
the possibility that thalamic deficits can causally contribute to cognitive dysfunction.
The role of MD activity in behavioral flexibility and working memory
Decreasing MD activity specifically impaired reversal learning while sparing the initial
discrimination learning. One brain area that is implicated in reversal learning and receives
direct projection from the MD is the OFC. It is therefore possible that disrupted
communication between these two structures may underlie the observed deficit in reversal
learning. In fact, both humans and non-human primates with damage to OFC are unimpaired
on discrimination tasks but show deficits in reversing stimulus-reward association within a
particular perceptual dimension (Berlin et al., 2004; Dias et al., 1997). As in primates, OFC
lesions in rats have been shown to impair reversal learning (Boulougouris et al., 2007;
Schoenbaum et al., 2002). Moreover OFC lesions across species have been repeatedly
associated with increase perseveration during reversal learning (Boulougouris et al., 2007;
Dias et al., 1996; Rolls et al., 1994). We also found that decreasing MD activity increased
perseverative errors during reversal phase. Indeed, CNO-treated MDhM4D mice responded
more during the presentation of the previously rewarded cue than the controls. This
phenomenon was already observed within the first session, during which controls but not
CNO-treated MDhM4D mice are able to repress their number of S- responses (Figure S3). It
is unlikely that this increase of S- responses during the reversal was due to general
hyperactivity because CNO-treated MDhM4D mice did not show hyperactivity in other
behavioral tasks, such as open field testing (Figure S4). Moreover, decreasing MD activity
did not increase the number of lever presses during the discrimination phase (data not
shown). As OFC lesions have been associated with impulsive behavior in humans (Berlin et
al., 2004), it is possible that CNO-treated MDhM4D mice may simply be unable to repress S-
responses due to increased impulsivity. This explanation is however unlikely because CNO-
treated MDhM4D mice did not show a deficit in repressing S- responses during the
discrimination phase.
We further showed that a decrease in MD activity induced a deficit in the acquisition in a
DNMS working memory task. This impairment is not due to a deficit in general attention or
deficits in learning the spatial contingencies of the task because CNO-treated MDhM4D mice
had no problems in learning a spatial version of the T-maze task. Decreasing MD activity
not only impaired the acquisition but also the performance of the DNMS task in trained
animals, sparing performance at short (6 to 30 s) delays but impairing performance at long
delays (60 to 120 s). One brain area that is implicated in working memory and receives
direct projection from the MD is the mPFC. Deficits in both acquisition and performance of
the DNMS T-maze task have been observed after lesioning or silencing the mPFC in rats
and mice (Dias and Aggleton, 2000; Kellendonk et al., 2006; Yoon et al., 2008). We
therefore hypothesize that disrupted communication between the MD and mPFC may
underlie the observed deficit in the working memory task. Our electrophysiological findings
discussed below are in line with this interpretation.
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MD-PFC functional connectivity during working memory
Here we report increases in synchrony between the MD and mPFC during a spatial working
memory task in control mice. During task acquisition, synchronized activity between these
two structures in the theta- and beta-frequency ranges increased hand in hand with
improvements in task performance. After successful acquisition, beta-frequency synchrony
was specifically enhanced in the working memory-requiring choice phase of the task, during
which mice need to keep information online to make the correct choice and obtain the
reward. Finally, lag analysis demonstrated that the MD leads the mPFC. These results are
consistent with the hypothesis that information flows from the MD to the mPFC in support
of working memory, similar to previous findings suggesting that hippocampal-prefrontal
interactions are also involved (Jones and Wilson, 2005; Sigurdsson et al., 2010). The precise
nature of the information contributed by MD inputs to the m PFC is unclear. Studies of MD
single unit activity during visual working memory in non-human primates have suggested
the possibility that MD units encode motor planning information (Watanabe and Funahashi,
2012). Considering the known inputs to the MD from the striatum and extrapolating from
these findings, it may be that the MD transmits motor information to the PFC about the
choice to be made during spatial working memory.
Our findings point to synchrony between the MD and mPFC in the beta-frequency (13 to 30
Hz) range as of particular relevance to the DNMS task. While the oscillations in the theta
and gamma bands have been classically linked to working memory, the functional role of
beta-band oscillations is less understood. However, recent studies performed in human and
non-human primates point to a role for beta-band oscillations in cognitive processes.
Specifically, elevations of beta-band activity in visual and prefrontal cortical areas have
been observed during the delay phase of working memory tasks (Deiber et al., 2007; Siegel
et al., 2009; Tallon-Baudry et al., 2001; Tallon-Baudry et al., 2004). Interestingly, beta-band
activity has also been linked to motor activity. Indeed, numerous studies provided the
evidence that beta activity is decreased during voluntary movements and increased during
holding periods following movement in a variety of structures belonging to the motor
system (for a review see (Engel and Fries, 2010)). Rather than reflecting a lack of
movement, a recent hypothesis proposed that beta rhythm would be related to the active
maintenance of the current sensorimotor set. According to this hypothesis, the role of beta
oscillations in cognition would be of similar nature and may be enhanced if the status quo is
given priority over distractive new signal, whereas gamma band activity may predominate if
changes in stimulus are expected (Engel and Fries, 2010). Therefore, beta oscillations may
relate to top-down processing and the increase of MD-PFC beta coherence observed during
the choice phase of the DNMS task may reflect the maintenance of the information
previously acquired during the sample phase of the task.
MD-PFC dysfunction in schizophrenia
The current findings are of potential relevance to the understanding of cognitive deficits in
schizophrenia. Imaging studies reported both deficits in MD and PFC (Andrews et al., 2006;
Minzenberg et al., 2009; Weinberger and Berman, 1996) in patients with schizophrenia
during cognitive tests. Moreover recent studies have found an altered correlation in the
activity of MD and PFC, suggesting that impaired functional connectivity between these
structures might underlie the cognitive difficulties (Minzenberg et al., 2009; Mitelman et al.,
2005). Structural abnormalities in this circuit have also been reported (Byne et al., 2009;
Marenco et al., 2012). However, one limitation of brain imaging is the low temporal
resolution that does not allow studying the complex spatial-temporal orchestration of brain
activity that is thought to underlie cognition. EEG methods offer a better temporal resolution
and some studies observed that synchronous activity of beta and gamma oscillations are
decreased in the cortex of patients with schizophrenia (for a review see (Uhlhaas and Singer,
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2010)). Our results indicate that the engagement of beta synchrony in working memory is
not restricted only to cortical areas but could also extend to thalamo-cortical circuits, and
more specifically, that beta-frequency oscillations may underlie thalamo-cortical
communication during working memory performance.
Our results further suggest that disruption of MD-PFC beta synchrony could participate in
the generation of cognitive deficits in schizophrenia. However, whether this disruption is of
primary origin in schizophrenia is hard to determine due to the circular nature of the brain.
Post mortem and structural brain imaging studies show morphological abnormalities in the
MD that suggest a primary deficit of the MD, at least in a subpopulation of patients (Byne et
al., 2009). However, the MD is also part of the well-described cortico-striatal loops in which
the striatum projects back to the cortex via the thalamus (Haber and Calzavara, 2009). A
primary role of the striatum for the pathogenesis of schizophrenia has been proposed
(Simpson et al., 2010). In this context, we previously showed that overexpression of striatal
dopamine D2 receptors, as a model for increased D2 receptor function observed in patients,
causes PFC-dependent cognitive deficits. These deficits included impairments in the here
presented DNMS T-maze working memory task (Kellendonk et al., 2006). One possibility is
therefore that altered striatal function could impact on the prefrontal cortex via altering MD
activity. Measuring MD-PFC synchrony in striatal D2 overexpressing mice would be a
useful test of this hypothesis.
The DREADD system as a tool to decrease MD activity
In this study, we chose a pharmacogenetic approach to reversibly reduce MD activity. The
DREADD system relies on a mutated human muscarinic G-protein coupled receptor that
does not respond to the endogenous ligand acetylcholine. The activation of these receptors
can be achieved by intraperitoneal injection of a biologically inert synthetic compound,
CNO. There has been concern regarding the potential retro-reduction of CNO to clozapine, a
well-known atypical antipsychotic drug (Loffler et al., 2012). However, for several reasons,
our results cannot be explained by this back metabolism. First, while CNO retro-reduction to
clozapine has been observed in humans and guinea pigs (Jann et al., 1994), back metabolism
could not be detected in rats and mice (Guettier et al., 2009; Jann et al., 1994). Second,
CNO-treated GFP-expressing control mice did not show any alteration in any of the tested
behaviors compared to saline groups. This includes behavior that have been shown to be
insensitive to clozapine such as locomotor activity (McOmish et al., 2012). Finally,
clozapine has been reported to alter MD firing (Lavin and Grace, 1998). While we found a
decrease in MD neuronal firing rate in MDhM4D mice injected with CNO (Figure 2B-D) we
did not see any firing rate changes in mice that do not express the hM4D receptor (Figure 2C
inset).
CONCLUSION
A major limitation of clinical studies is that they cannot draw causal relations between
observed anatomical/functional deficits and specific symptoms. Using pharmacogenetic
tools in combination with in vivo recordings from awake behaving animals we found that
even a subtle decrease in MD activity can lead to altered MD-PFC functional connectivity
and prefrontal-dependent cognitive deficits. Based on these findings we propose that
abnormalities found in the MD of patients with schizophrenia could participate to the
pathogenesis of cognitive deficits.
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All protocols used in the present study were approved by the Institutional Animal Care and
Use Committee (IACUC) at Columbia University. Mice were C57/Bl6 males purchased
from Jackson Laboratory and housed under a 12-h, light-dark cycle in a temperature-
controlled environment with food and water available ad libitum. For the behavioral
experiments (reversal learning and T-maze tasks) mice were food restricted and maintained
at 85% of their initial weight. For this, they were limited to 1 h 30 daily access to food in the
home cage. After testing, mice were sacrificed and the expression as well as the location of
GFP expression was verified to ensure that we correctly targeted the MD (Figure S5). Mice
for which GFP was not visible or in an incorrect location were removed from the final
analysis.
Drugs
Clozapine-N-Oxide (CNO) (sigma) was dissolved in PBS to a final concentration of 0.2 mg/
ml. PBS or CNO (2 mg/kg) was administered intra-peritoneal to the mice 30 min before
behavioral testing or in vivo recording (based on personal observations and Alexander et al.
2009). For thalamic slice physiology CNO was diluted into 1 μM with artificial
cerebrospinal fluid. Fresh CNO solution was prepared on the day of usage.
Generation of AAV2-hM4D and virus injection
The AAV2-hM4D-IRES-hrGFP (called later AAV2-hM4D) virus was generated by
inserting the hM4D sequence into the multiple cloning site of the pAAV-IRES-hrGFP
vector (Agilent Technologies). The AAV2-hM4D-IRES-hrGFP and control (AAV2-hrGFP)
viruses were produced by Vector Biolabs (Eagleville, PA). Mice were injected bilaterally
with 0.5 μl of AAV2-hM4D (1.04 × 1013 particles/ml) or AAV2-hrGFP (1 × 1012 particles/
ml). Viruses were pressure injected using a glass pipette (10-15 μm) into the MD
(coordinates: A/P, -1.3 mm; M/L, ±0.35 mm; D/V, -3.2 mm). After each injection, the
pipette remained in situ for 10 min to minimize leaking. 6 weeks-old mice were injected and
then tested 4 weeks later for both behavioral and in vivo electrophysiology studies. For
thalamic slice recordings, 3 weeks-old mice were injected and sacrificed 3 weeks later.
Histology and immunostaining
Histology and immunostaining was performed using classical methods (see supplemental for
more details). HA rabbit-polyclonal (Invitrogen # 71-5500) antibody was diluted 1/1000 in
PBS and incubated overnight at 4dC. Anti NeuN (Millipore, MAB377) HC was performed




Discrimination phase: This phase was done under a VI 20 s schedule. During the
discrimination task, lever presses were reinforced depending on which of two visual stimuli
(a flashing and a steady house light) were present. Lever presses in the presence of one of
the stimuli (S+) were rewarded according to the VI 20 s schedule. Lever presses in the
presence of the other stimulus (S-) did not lead to any reward. One session was composed by
20 S+ and 20 S- trials. S+ and S- trials were selected randomly and were separated by a
variable ITI during which the house light was turned off. The duration of S+ trials was 1
min. Thus, the average number of rewards earned during S+ trials was 60. S- trials were also
1 min in duration. However a 20 s penalty was included such that mice were required to
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withhold lever presses for 20 s in order for the next trial to commence. l. Mice performed
one session per day, and the discrimination phase ended after 7 sessions were completed.
Reversal phase: During this phase, all experimental events occurred in the same manner as
the discrimination phase, except that the reward contingencies were reversed so that the S+
became S- and vice versa. One session was composed by 20 S+ trials and 20 S-. Again, mice
performed one session per day, and the reversal phase ended after 7 sessions were
completed.
Non-Matching to sample T-maze task—We used the methods described previously
(Sigurdsson et al., 2010). Briefly, mice were tested on 10 trials per day, each trial consisting
of two runs, a forced run and a choice run. To obtain a reward, animals were required to
enter the goal arm not visited during the forced phase. Animals were given daily training
sessions of 10 trials until they reached criterion performance, defined as performance of a
minimum of seven trials correct per day for three consecutive days. After the mice reached
criterion, there performance was tested on different delays of 6 s, 30 s, 60 s, 90 s, 120 s and
180 s with 10 trials per delay.
Spatial T-maze task—The spatial version of the T-maze used the same maze apparatus
and habituation procedure than the non-matching to sample task. Only the rule to acquire the
task differed. For all trials each mouse was assigned one arm, left or right, as the baited
target arm. Mice use an allocentric or spatial strategy to solve this task. Mice were trained
ten trials per day and criterions were fixed at seven correct choices out of ten during three
consecutive days.
In Vivo recordings
Microdrive construction and Surgery—Animals were implanted with multiwire
microdrives using methods described previously (Adhikari et al., 2010). For more details,
see supplemental methods.
Behavior and neurophysiological data acquisition—Mice used for “task
independent” MD single unit activity (Figure 2B-D) were recorded during free exploration
of the T-maze. Mice were injected i.p. with saline solution and recorded 30 minutes after the
injection during 15 minutes. After this, without moving the stereotrodes, mice were injected
i.p. with CNO and recorded 30 minutes after the injection during 15 minutes. Mice used for
“working memory task dependent” recordings were performing the previously described T-
maze DNMS task during data acquisition. We restricted our analysis to neural activity in the
center arm of the maze during sample and choice phases. This had the advantage of
minimizing behavioral variability, as both trajectories and speeds of center-arm runs were
comparable in saline- and CNO-treated and MDhM4D mice. Recordings were obtained via a
unitary gain head-stage preamplifier (HS-32; Neuralynx) attached to a fine wire cable. Field
potential signals from MD, mPFC and dHPC sites were recorded against a screw implanted
in the anterior portion of the skull. LFPs were amplified, bandpass filtered (1–1,000 Hz) and
acquired at 1893 Hz. Spikes exceeding 40 μV were bandpass-filtered (600–6,000 Hz) and
recorded at 32 kHz. Both LFP and spike data were acquired with Lynx 8 programmable
amplifiers on a personal computer running Cheetah data acquisition software (Neuralynx).
The animal's position was obtained by overhead video tracking (30 Hz) of two light-emitting
diodes affixed to the head stage.
Firing rate and burst analysis—Data was imported into Matlab for analysis using
custom-written software. Instantaneous firing rate for the example cell in Figure 2B was
smoothed using Matlab smooth with a 60s moving average. To test the significance of firing
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rate changes, we used both a population analysis and an individual cell analysis. For the
population analysis we used a sign rank test to determine whether the distribution of firing
rate rations (CNO:SAL) were significantly different from a distribution with a median of 1.
For the individual cell analysis each 15 min recording session under either saline or CNO
conditions were separated into 30s bins and firing rate was calculated. A one-factor
ANOVA was performed on each cell to determine whether the mean firing rate after CNO
was significantly different from that after SAL, with and without Bonferroni correction as
described in the text. The predominance of decreases vs. increases in firing rate using this
method was then also tested using a Binomial test. For burst analysis, a burst was defined by
the following criteria: maximum interval to start burst (i.e., the first interspike interval
within a burst) must be =4 ms; maximum interval to end burst, 10 ms; minimum interval
between bursts, 100 ms; minimum duration of burst, 4 ms; and minimum number of spikes
within a burst, two.
Phase locking analysis—Phase locking of MD units to mPFC LFPs was accomplished
by fist filtering the field potentials in either the theta (4-12 Hz) beta (13-30Hz) or gamma
(40-60Hz) range using a zero phase delay filter and computing phase using a Hilbert
transform. Each unit spike was assigned a phase based on its simultaneous field potential
sample. The magnitude of phase locking was quantified mean resultant length (MRL) of the
sum of the unit vectors representing the phases at which each spike occurred, divided by the
number of spikes. The MRL is sensitive to the number of spikes used in the analysis.
Therefore, to compare phase locking strength by condition we computed the MRL for
multiple (1000) subsamples of 50 spikes per condition and averaged across subsamples for
each condition, and for each unit. Units that fired fewer than 50 spikes in each condition
were not analyzed. The statistical significance of phase-locking was assessed using the
Rayleigh test for circular uniformity.
Directionality Analysis—Data was pooled for task independent and task dependent
behavior sessions. Cells with fewer than 600 spikes during the entire recording session were
not analyzed. To determine the temporal relationship between unit activity and beta
oscillations in the mFPC, phase locking was calculated for 50 different temporal offsets
from the mPFC LFP for each unit recording. Only units with significant Bonferroni-
corrected phase locking in at least one of the 50 shifts are shown in Figure 5C.
Field Potential Analysis—For coherence and behavior across learning, recordings were
binned into early (first 5 trials), middle (trials 25-30) and late (last 5 trials on the day the
animal achieved criterion performance) trials. Coherence of the field potentials was
computed using the multitaper method (MATLAB routines provided by K. Harris). Field
potential samples for the trials in each bin were concatenated and then divided into 1000 ms
segments (800 ms overlap). The Fourier transform of each segment was computed after
being multiplied by two orthogonal data tapers. Coherence was computed by averaging the
cross-spectral densities of two field potential signals across data windows and tapers and
normalizing to the power spectral densities of each signal. Beta coherence was computed as
the mean coherence in the 13-30 Hz range.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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1. A mild decrease in MD activity triggers impairments in PFC-dependent
cognitive tasks.
2. MD-PFC beta-synchrony is selectively modulated during a spatial working
memory task.
3. Decreasing MD activity disrupts MD-PFC synchrony during high working
memory demand.
4. Decreasing MD activity delays task acquisition and correlated increases in
synchrony.
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Figure 1. Expression of hM4D in the medio-dorsal thalamus using viral vector
(A) Schematic drawing of pAAV2-hM4D-IRES-hrGFP plasmid. Both hM4D (red) and
hrGFP (green) are expressed under the control of a cytomegalovirus (CMV) promoter
(yellow). (B) Native hrGFP fluorescence (green) and anti-HA immunostaining (red) reveal
co-expression (yellow) of GFP and hM4D in MD cells. (C) Top panel: native hrGFP and
anti-NeuN immunostaining (red) reveal that hrGFP is exclusively expressed in neurons.
Bottom panel: stereotactic injection of the AAV2-hM4D-IRES-hrGFP leads to transgene
expression in 27 ±6% of MD neurons with a peak at 66 ±9.6% at the site of infection (n=4).
(D) GFP labels the MD projections to the PFC after injection with a hrGFP control virus in
the MD. Abbreviations: prelimbic (PrL), medial ventral orbital (VO), lateral orbital (LO)
dorsolateral orbital (DLO) cortices, I, III/V depict cortical layers. See also figure S1.
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Figure 2. Decreasing activity in the medio-dorsal thalamus using a pharmaco-genetic approach
(A) Left panel: visualization of hM4D ires hrGFP expressing neurons in a thalamic slice.
Right panel: Resting membrane potential of MD neurons infected with control hrGFP
(green) and experimental hM4D ires hrGFP (orange) virus before and after bath application
of 1 μM CNO (repeated measures ANOVA, group x treatment interaction ***p<0.001;
n=11 and 10 cells for hrGFP and hM4D-hrGFP cells). (B) Example of MD unit activity in
vivo before (green) and after (orange) systemic injection of 2 mg/kg CNO to anMDhM4D
mouse. (C) Histogram of the ratios of firing rate after CNO to firing rate after saline in
MDhM4D mice. Red and blue bars represent cells with statistically significant increases or
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decreases in firing rate, respectively. Inset: histogram of the ratios of firing rate after CNO to
firing rate after saline in wild-type mice. (D) Firing rate after saline vs. firing rate after CNO
for entire sample of 63 MD units. Red and blue circles indicate units with statistically
significant increases or decreases in firing rate, respectively (p<0.05, paired t-test). Inset is a
magnified view of lower firing-rate neurons. Error bars: s.e.m.See also figure S2.
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Figure 3. Decreasing activity in the medio-dorsal thalamus leads to deficits in behavioral
flexibility
(A) Task design for the operant-based reversal-learning task. (B and C) Acquisition curves
for discrimination (B) and reversal (C) demonstrate a selective impairment in reversal
learning in CNO-treated MDhM4D mice. (Discrimination: repeated measures ANOVA, time
p<0.001, group p=0.3593; GFP-sal n=23, GFP-CNO n=7, hM4D-sal n=42 and hM4D-CNO
n=11; Reversal; repeated measures ANOVA followed by Bonferroni post-hoc tests,
*p<0.05, **p<0.01; GFP-sal n=15, GFP-CNO n=14, hM4D-sal n=26 and hM4D-CNO
n=25). (D) S- lever pressing during the reversal phase. All mice decreased responding over
time (repeated measures ANOVA, main effect of time, p<0.001). However, only CNO-
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treated MDhM4D mice made more perseverative errors (repeated measures ANOVA
followed by Bonferroni post-hoc analysis *p<0.05, ***p<0.001). Error bars: s.e.m. See also
Figure S3.
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Figure 4. Decreasing activity in the medio-dorsal thalamus leads to deficits in working memory
(A) Task design for the T-maze based DNMS working memory task. (B) CNO-treated
MDhM4D mice showed a deficit in acquisition (left panel) and took longer to reach criterion
(right panel) compared to control groups (delayed task) (ANOVA followed by Newman-
Keuls post-hoc analysis *p<0.05; GFP-sal n=7 GFP-CNO n=6, hM4D-sal n=12 and hM4D-
CNO n=11). (C) CNO-treatment impaired DNMS performance on long delays in MDhM4D
mice after task acquisition (repeated measures ANOVA, group effect *p<0.05; combined
controls n=21 including 5 GFP-sal, 4 GFP-CNO and 12 hM4D-sal; hM4D-CNO n=11). (D)
Decreasing MD activity does not affect acquisition of a spatial reference memory T-maze
Parnaudeau et al. Page 23













task (two-tailed t-test p=0.98; hM4D-sal n=15 and hM4D-CNO n=14). Error bars: s.e.m.
See also figure S4.
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Figure 5. Enhancement of thalamo-prefrontal beta synchrony during working memory
performance is disrupted by low MD activity
(A) Phase locking of MD cells to mPFC LFP oscillations in the beta-, theta- and gamma-
frequency range as a function of task phase (sample vs choice) (repeated measures ANOVA,
group x task phase interaction #p<0.05; hM4D-SAL cells n=40 (green), hM4D-CNO cells
n=33 (orange); sample-choice difference in controls, **p < 0.01 by paired t-test). (B) Phase
locking of MD cells to dHPC LFP oscillations in the beta-, theta- and gamma-frequency
range as a function of task phase (sample vs choice) (paired t-test sample-choice difference
in controls and CNO-treated MDhM4D mice, ***p < 0.001; hM4D-SAL cells n=40 (green),
hM4D-CNO cells n=33 (orange)). (C) Upper panel, normalized beta-phase locking strength
as a function of lag to mPFC LFP for all MD cells with significant phase-locking to the
mPFC, ordered by lag at which peak strength occurs. Bottom: distribution of lags at peak
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phase locking strength (lag, +20 ± 1.4 ms, wilcoxon signed rank test p<0.05, n=73). Error
bars: s.e.m. See also Figure S5.
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Figure 6. Synchronous activity between medio-dorsal thalamus and prefrontal cortex correlates
with behavioral performance in a spatial working memory task
(A) Example of coherence spectra between early (trials 1-5; dashed lines) and late (5 last
trials; solid lines) training phase in saline- (green) and CNO- (orange) treated MDhM4D
mice. (B) Time course of increases in MD-PFC beta coherence (top panels) and choice
accuracy (bottom panels) in saline- (green, n=9) and a CNO- (orange, n=10) treated
MDhM4D mice (repeated measures ANOVA followed by Fischer post-hoc analysis,
difference versus trials 1-5, °p<0.1 *p<0.05, **p<0.01, ***p<0.001). (C) Correlation
analysis between beta-coherence and choice accuracy for each session (10 trials per session)
in saline- (green) and CNO- (orange) treated MDhM4D mice (Pearson correlation test, saline:
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correlation coefficient r=0.3, p<0.05, CNO: r=0.407, p<0.001). Error bars: s.e.m. See also
Figure S6.
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